Table 1. Associations of miR-191 Expression in ESCC Tissues with Demographic and Clinicopathologic Characteristics.
Category | n=93 | miR-191 expression | p value* | |
---|---|---|---|---|
Low (n=41) | High (n=52) | |||
Gender | 0.976 | |||
Male | 77 | 34 | 43 | |
Female | 16 | 7 | 9 | |
Age | 0.144 | |||
≤65 | 51 | 19 | 32 | |
>65 | 42 | 22 | 20 | |
Tumor size, cm | 0.697 | |||
<5 | 52 | 22 | 30 | |
≥5 | 41 | 19 | 22 | |
Differentiation | 0.037 | |||
Well and moderate | 57 | 30 | 27 | |
Poorly and not | 36 | 11 | 25 | |
Depth of invasion | 0.010 | |||
T1–T2 | 24 | 16 | 8 | |
T3–T4 | 69 | 25 | 44 | |
Stages | <0.001 | |||
I–II | 50 | 32 | 18 | |
III–IV | 43 | 9 | 34 | |
Lymph node metastases | <0.001 | |||
0 | 45 | 28 | 17 | |
≥1 | 48 | 13 | 35 | |
Metastases to other organs | 0.025 | |||
Present | 6 | 0 | 6 | |
Absent | 87 | 41 | 46 |
miR-191, microRNA-191; ESCC, esophageal squamous cell carcinoma.
*p values were calculated through the χ2 test to analyze the relationship between miR-191 expression and clinicopathologic characteristics.